PlainRecalls
FDA Drug Low Class III Terminated

SINUVA (mometasone furoate) sinus implant, 1350 mcg, 1 implant per pouch, Rx Only, intersect ENT, 1555 Adams Drive, Menlo Park, CA 94025, NDC 10599-003-01.

Reported: January 25, 2023 Initiated: January 4, 2023 #D-0167-2023

Product Description

SINUVA (mometasone furoate) sinus implant, 1350 mcg, 1 implant per pouch, Rx Only, intersect ENT, 1555 Adams Drive, Menlo Park, CA 94025, NDC 10599-003-01.

Reason for Recall

Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.

Details

Recalling Firm
Intersect ENT, Inc.
Units Affected
9898 pouches
Distribution
Nationwide
Location
Menlo Park, CA

Frequently Asked Questions

What product was recalled?
SINUVA (mometasone furoate) sinus implant, 1350 mcg, 1 implant per pouch, Rx Only, intersect ENT, 1555 Adams Drive, Menlo Park, CA 94025, NDC 10599-003-01.. Recalled by Intersect ENT, Inc.. Units affected: 9898 pouches.
Why was this product recalled?
Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 25, 2023. Severity: Low. Recall number: D-0167-2023.